← Back to Viksnins Harris Padys Malen LLP
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19228322 | HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE | Regents Of The University Of Minnesota | NUR, ABDULLAHI | 2877 | §103Other | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19191629 | METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF AN AAK1 INHIBITOR | Lexicon Pharmaceuticals, Inc. | HASTINGS, ALISON AZAR | 1627 | DP | Non-Final OA | — | Pending | Apr 28, 2025 |
| 19184578 | PULMONARY ARTERY FLOW RESTRICTOR | Regents Of The University Of Minnesota | ORKIN, ALEXANDER J | 3771 | §103 | Final Rejection | — | Pending | Apr 21, 2025 |
| 19070289 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Ardelyx, Inc. | SEAMAN, D MARGARET M | 1625 | DP | Non-Final OA | — | Pending | Mar 04, 2025 |
| 19053009 | COMPOUNDS AND METHODS FOR TREATING CHEMOTHERAPY-INDUCED PAIN | Lexicon Pharmaceuticals, Inc. | BRAUN, MADELINE E | 1624 | §102§103Other | Non-Final OA | — | Pending | Feb 13, 2025 |
| 18997744 | TGFB TREATMENT OF ORGANOID CULTURES TO PRIME FOR REGENERATIVE THERAPY OF DAMAGED GI EPITHELIA | Rutgers, The State University Of New Jersey | JACKSON III, WALTER | 1638 | §103 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18961937 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS BY VIRUS PARTICLES IN PLANTS | The Regents of the University of California | ROBINSON, KEITH O NEAL | 1661 | §103§112Other | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18958741 | SYNTHETIC PROCESSES AND SYNTHETIC INTERMEDIATES | Taxis Pharmaceuticals, Inc. | BURKETT, DANIEL JOHN | 1625 | §102§112DP | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18859673 | NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE | The Board Of Regents Of The University Of Texas System | HIRAKIS, SOPHIA P | 1623 | §102§112 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18852384 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | The Regents of the University of California | BERRIOS, JENNIFER A | 1613 | §101§103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18897158 | METHODS OF TREATING TYPE 1 DIABETES AND KIDNEY DISEASE | Lexicon Pharmaceuticals, Inc. | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §102§103§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18846873 | THERAPEUTIC COMPOUND AND SALTS | Regents Of The University Of Minnesota | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18838564 | FILLED FOOD PRODUCTS AND METHODS OF PREPARING SAME | Yb Foods LLC | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18724911 | METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS | The Regents of the University of California | SHEN, YANXIN NMN | 1663 | §103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18722252 | ANTI-MASP-2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shenyang Sunshine Pharmaceutical Co., Ltd. | STEPHENS, AMELIA CAROLE | 1645 | §102§103§112Other | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18669075 | BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY | Cognizance Biomarkers, Inc. | ORWIG, KEVIN S | 3991 | Other | Non-Final OA | — | Pending | May 20, 2024 |
| 18662929 | NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | Ardelyx, Inc. | SHIAO, REI TSANG | 1691 | §112DP | Non-Final OA | — | Pending | May 13, 2024 |
| 18648062 | THERAPEUTIC COMPOUNDS | Rutgers, The State University Of New Jersey | CORNET, JEAN P | 1628 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18705175 | TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF | Regents Of The University Of Minnesota | ONDACHI, PAULINE WANJIKU MUCH | 1627 | §103DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18633908 | THERAPEUTIC COMPOUNDS | Regents Of The University Of Minnesota | MILLER, DALE R | 1693 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | The Regents of the University of California | SULLIVAN, STEPHANIE LAUREN | 1635 | §102§103 | Final Rejection | 131d overdue | Pending | Apr 12, 2024 |
| 18700140 | IMPROVED CEREBRAL ANGIOGRAPHY CATHETER | Rutgers, The State University Of New Jersey | FERNANDEZ, KATHERINE L | 3798 | §103 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18613381 | USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS | Lexicon Pharmaceuticals, Inc. | CRAIGO, BAHAR ALAWI | 1699 | §101§102§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18593314 | CONJUGATES AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | BOWERS, ERIN M | 1653 | §102§103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18683583 | DUAL-TARGETED RNA POLYMERASE INHIBITORS: CONJUGATES OF BENZOXAZINO- AND SPIRO-RIFAMYCINS WITH N ALPHA-AROYL-N-ARYL-PHENYLALANINAMIDES | Rutgers, The State University Of New Jersey | SEITZ, ANTHONY JOSEPH | 1629 | §103§112Other | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18424215 | FORTIFIED CONFECTION COMPOSITIONS | Glanbia Dairy Nutrition Limited | STULII, VERA | 1791 | §102§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18403891 | HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY | Regents Of The University Of Minnesota | BRAZIN, JACQUELINE | 1798 | §102§112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18572411 | THERAPEUTIC COMPOUNDS | Taxis Pharmaceuticals, Inc. | CHENG, KAREN | 1623 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18517049 | PHARMACOLOGICAL DEPLETION OF HEME FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME | The Scripps Research Institute | NEAGU, IRINA | 1629 | §102§103 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18381799 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | Ardelyx, Inc. | SONG, JIANFENG | 1613 | §103Other | Final Rejection | — | Pending | Oct 19, 2023 |
| 18286955 | Glycan Targets of Serum IgG and IgM Antibodies | Regents Of The University Of Minnesota | WEN, SHARON X | 1641 | §103 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18372535 | CATALYSTS | The Regents of the University of California | SPIES, BRADLEY R | 1742 | §102§103 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18283071 | 2-AMINO-4-CARBOXAMIDE-BENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | METCALF, MATTHEW CURRAN | 1647 | §103DP | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18548635 | HETEROBIFUNCTIONAL COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION AND METHODS FOR THEIR USE | The Scripps Research Institute | CHANDRAKUMAR, NIZAL S | 1625 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §112 | Final Rejection | 23d overdue | Pending | Aug 29, 2023 |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | FRONDA, CHRISTIAN L | 1652 | §103§112 | Non-Final OA | 70d | Pending | Aug 16, 2023 |
| 18546217 | SMALL MOLECULE ACTIVATORS OF YAP TRANSCRIPTIONAL ACTIVITY FOR REGENERATIVE ORGAN REPAIR | The Scripps Research Institute | BRAUN, MADELINE E | 1624 | §103§112 | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | Denali Therapeutics Inc. | LU, CHENG | 1642 | §102§103§112Other | Non-Final OA | 46d | Pending | Aug 10, 2023 |
| 18228422 | SELECTIVE BRD4-DEGRADER MOLECULES | Regents Of The University Of Minnesota | BURKETT, DANIEL JOHN | 1624 | §112 | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18274863 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | GWARTNEY, ELIZABETH A | 1759 | §103 | Final Rejection | 35d overdue | Pending | Jul 28, 2023 |
| 18274907 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | BEKKER, KELLY JO | 1792 | §103§112 | Final Rejection | 84d | Pending | Jul 28, 2023 |
| 18274412 | INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | BANERJEE, KOYELI | 1658 | §103 | Final Rejection | 13d | Pending | Jul 26, 2023 |
| 18270162 | SENSE,SUPPRESSOR TRANSFER RNA COMPOSITIONS AND RELATED USES AND FUNCTIONS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | GROOMS, TIFFANY NICOLE | 1637 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18035695 | TARGETED CONJUGATES COMPRISING MODIFIED SIRNA | Arbutus Biopharma Corporation | TATGE, LEXUS MARC | 1637 | §102§103§112DP | Non-Final OA | — | Pending | May 05, 2023 |
| 18141728 | MASKED SINGLE-DOMAIN ANTIBODIES AND METHODS THEREOF | Regents Of The University Of Minnesota | TAYLOR, LIA ELAN | 1641 | §112 | Final Rejection | 19d | Pending | May 01, 2023 |
| 18032768 | METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE | UNIVERSITY OF IOWA RESEARCH FOUNDATION | PAK, JOHN D | 1699 | §102§103§112 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18120204 | MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION | MEYERING, SHABANA SHABBEER | 1635 | §101§112 | Non-Final OA | — | Pending | Mar 10, 2023 |
| 18110292 | METHOD FOR PREPARING ACTIVATED CARBON | The Regents of the University of California | MENON, KRISHNAN S | 1777 | §102§103 | Final Rejection | 191d overdue | Pending | Feb 15, 2023 |
| 18017541 | PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | DAHLIN, HEATHER RAQUEL | 1629 | §112 | Final Rejection | 2d overdue | Pending | Jan 23, 2023 |
| 18010108 | BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER | Minomic International Ltd. | POHNERT, STEVEN C | 1683 | §101§103§112Other | Non-Final OA | 77d | Pending | Dec 13, 2022 |
| 17923171 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2 | The Scripps Research Institute | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §102§103 | Non-Final OA | 65d | Pending | Nov 03, 2022 |
| 17918448 | GUANIDINE-MODIFIED C-TERMINUS VANCOMYCIN COMPOUNDS, COMPOSITIONS AND METHODS | The Scripps Research Institute | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | 30d overdue | Pending | Oct 12, 2022 |
| 17910657 | SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE | Lipoid GmbH | ZILBERING, ASSAF | 1792 | §103 | Non-Final OA | — | Pending | Sep 09, 2022 |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | Denali Therapeutics Inc. | CHANDRA, GYAN | 1674 | §103DP | Final Rejection | 37d overdue | Pending | Aug 04, 2022 |
| 17706919 | SARS-CoV-2 SPIKE ECTODOMAIN POLYPEPTIDES AND COMPOSITIONS AND METHODS THEREOF | Regents Of The University Of Minnesota | EVANS, CHRISTOPHER RYAN | 1677 | §103 | Final Rejection | — | Pending | Mar 29, 2022 |
| 17533991 | HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR | The Chinese University of Hong Kong | HURST, JONATHAN M | 1799 | §103 | Final Rejection | 8d overdue | Pending | Nov 23, 2021 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | Denali Therapeutics Inc. | AEDER, SEAN E | 1642 | §103 | Final Rejection | 15d overdue | Pending | May 24, 2021 |
